The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Kazuya TanimuraSusumu SatoYukio FujitaYoshifumi YamamotoTakashi HajiroNobuyuki HoritaTomotaka KawayamaShigeo MuroPublished in: Chronic respiratory disease (2023)
Additional treatment with SAMA combined with LABA could be a feasible choice due to its efficacy and safety.
Keyphrases